NIH: Investigational vaccine neutralizes multiple MERS-CoV strains

An investigational vaccine called ChAdOx1 MERS protected two groups of rhesus macaques from disease caused by Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV is a relative of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19). National Institutes of Health scientists and colleagues are pursuing similar studies with ChAdOx1 SARS2, ["]

The post NIH: Investigational vaccine neutralizes multiple MERS-CoV strains appeared first on Outbreak News Today.